Results 241 to 250 of about 8,720,014 (305)

A Novel Pak1 Activator Ameliorates ER Stress for HFpEF Therapy

open access: yesAdvanced Science, EarlyView.
Chronic metabolic stress is a major contributor to HFpEF progression. Under prolonged metabolic stress, Pak1 activity becomes impaired, contributing to disrupted ER proteostasis, cardiomyocyte apoptosis, fibrosis, and diastolic dysfunction. Mechanistically, Pak1 overexpression activates the ERK1/2–MNK1–eIF4E signaling axis, promotes translational ...
Honglin Xu   +17 more
wiley   +1 more source

Extravascular distribution of factor IX-review of experimental and clinical evidence, and relevance for hemophilia B replacement therapy. [PDF]

open access: yesRes Pract Thromb Haemost
Hermans C   +6 more
europepmc   +1 more source

Basement membrane turnover controls cell shape. [PDF]

open access: yesCell
Barrientos R   +8 more
europepmc   +1 more source

Monocyte-Derived LGMN<sup>+</sup> Macrophages Divert Lung Injury Outcomes toward Fibrosis through Matrix Remodeling. [PDF]

open access: yesResearch (Wash D C)
Li Z   +10 more
europepmc   +1 more source

Age-dependent vascular and neurological characteristics of CADASIL are recapitulated in Notch3 mutant zebrafish, implicating a role for type IV collagen in disease progression. [PDF]

open access: yesActa Neuropathol Commun
Kanoh T   +11 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Type-IV collagen related diseases

Journal of Nephrology, 2003
  Alport syndrome (ATS) is a progressive inherited glomerulonephritis accounting for 1-2% of all patients who start renal replacement therapy, with an estimated gene frequency of approximately 1 in 5000. ATS is a genetically heterogeneous disease, commonly inherited as an X-linked semi-dominant trait, caused by mutations in COL4A5, on
PESCUCCI C.   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy